Concepedia

Andreas Sonyi

AS

Statistics

Publications

5

Citations

263

H-Index

5

Active since

2018

Affiliations

Eli Lilly (United States)(Current)

Andreas Sonyi is an author at Eli Lilly (United States) specializing in cancer immunotherapy, cancer immunology, and checkpoint inhibitor therapy.

Publications per year

2018–2020

5

Publications

5